95%Confidence
0Views
FDASource
2026-04-19Date
Summary
K.C. Pharmaceuticals' sterility assurance failure for multiple eye drop products distributed through major retailers creates significant consumer safety concerns. This affects multiple brands including Leader and Good Sense, potentially triggering widespread recalls across retail channels.
Actionable: Immediately quarantine affected eye drop products and notify customers of potential safety issues.
AI Confidence: 95%
Data Points
firmK.C. Pharmaceuticals, Inc
classificationClass II
statusOngoing
distributionNationwide in the US
productArtificial Tears Sterile Lubricant Eye Drops (polyvinyl alcohol 0.5%, povidone 0.6%), 0.5 FL OZ (15 mL) bottles; a) LEADER, DISTRIBUTED BY CARDINAL HE
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now